NEWS

NEWS TYPE
RELEASE YEAR

RESEARCH

[Publication] Highly Selective Cytokine Induction of Nitrated Lipid-Modified α-GalCer Derivatives Demonstrating High Binding Affinity to the Lipid Antigen Presenting Molecule CD1d

March 10, 2025

Title Highly Selective Cytokine Induction of Nitrated Lipid-Modified α-GalCer Derivatives Demonstrating High Binding Affinity to the Lipid Antigen Presenting Molecule CD1d
Authors Kodai Sueyoshi [1],[2]; Junichiro Kishi [1]; Shinsuke Inuki [3]; Takanori Matsumaru [1]; Yukari Fujimoto [1],[2]
DOI https://doi.org/10.1002/chem.202403871
Journal Chemistry
Vol/Num/Page 2025 Jan 27; 31(6):e20243871
Publication Date Published online: 2025 Jan 5.

Affiliations:
[1] Graduate School of Science and Technology, Keio University, 3-14-1, Hiyoshi, Kohoku-ku, Yokohama, Kanagawa, 223-8522, Japan.
[2] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
[3] Graduate School of Biomedical Sciences, Tokushima University, 1-78-1, Shoumachi, Tokushima, Tokushima, 770-8505, Japan.

More Bio2Q News

ANNOUNCEMENT
2025.10.17

Open Call: Postdoctoral Fellow for Professor Daniel R. Mende’s Lab

Prof. Daniel R. Mende, specializing in computational biology, microbiome research, metagenomics, pangenomics, AI/ML, and multi-omics data an...

ANNOUNCEMENT
2025.10.17

Open Call: Postdoctoral Fellow for Professor Nadinath Nillegoda’s Lab

Prof. Nadinath Nillegoda, specializing in proteostasis and cell repair, is currently hiring a postdoctoral fellow. We are looking for appli...

EVENT
2025.10.09

WPI-Bio2Q Social Event (2025.9.29)

WPI-Bio2Q held a social event at Keio University's Shinanomachi Campus. Date & Time: Monday, September 29, 2025 Venue: Bio2Q Open La...

EVENT
2025.10.08

【Event】Keio Alumni Association Convention 2025

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will give a presentation at the Keio Alumni Association Convent...

EVENT
2025.10.07

Visit to Bio2Q by Dr. Hitoshi Nakagama, President of the Japan Agency for Medica...

On September 22, 2025, Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED), visited Bio2Q. Admi...